California Health & Safety Code § 1250.3 California CDPH Licensed Chemical Dependency Recovery Hospital (CDRH) attorney fee petition mechanics: CDPH Healthcare Facility Information System (HFIS) at facilities.cdph.ca.gov as primary Welch anchor — ASAM Criteria for Level 4.0 Medically Managed Intensive Inpatient Services (2023 Edition) Advisory and NAATP Standards for Member Programs (2023 Edition) Advisory — TWO PRIVATE STANDARDS — PURE KETCHUM

Billing gap 1 — CDPH HFIS license verification, ASAM Criteria Level 4.0 advisory, and NAATP Standards advisory hours (5.25 hrs)

Every California professional licensing board fee petition under Code of Civil Procedure § 1021.5 begins with the institutional threshold verification that grounds the entire fee petition chronology. For a California CDPH Licensed Chemical Dependency Recovery Hospital matter under Health & Safety Code § 1250.3, the attorney begins with the CDPH Healthcare Facility Information System (HFIS) Verification portal at facilities.cdph.ca.gov — the primary Welch anchor. The CDPH Healthcare Facility Licensing and Certification Program administers the California Health Facility Licensing Law, issuing licenses to all categories of California health facilities including Chemical Dependency Recovery Hospitals (§ 1250.3), General Acute Care Hospitals (§ 1250(a)), Psychiatric Health Facilities (§ 1250.2), Skilled Nursing Facilities (§ 1250(b)), Outpatient Surgery Clinics (§ 1248), Chronic Dialysis Clinics (§ 1204), and numerous other facility types; the facilities.cdph.ca.gov HFIS portal provides public access to the license record for each CDPH-licensed facility, including the facility's name and address, CDPH facility number, license type, current license status (active, expired, suspended, revoked), license expiration date, and any CDPH enforcement history including deficiency citations, Immediate Jeopardy determinations, conditional licensing orders, and criminal referrals. An attorney investigating a § 1250.3 unlicensed CDRH matter accesses facilities.cdph.ca.gov, searches the respondent's facility name, physical address, or CDPH facility number, and receives one of four possible findings: a license record confirming an active § 1250.3 CDRH license in good standing with the current expiration date; a license record showing a § 1250.3 CDRH license exists but has lapsed into expired or suspended status with the specific expiration date establishing the beginning of the unlicensed operating period; a license record confirming the facility holds only a different CDPH license category — such as a Psychiatric Health Facility under § 1250.2 — but no CDRH license under § 1250.3, establishing the § 1250.3 violation for medically managed detoxification regardless of the other CDPH license held; or no license record at all, confirming complete absence of any CDPH health facility license. This HFIS record — specifically the finding that the respondent holds no active § 1250.3 CDRH license (the Los Angeles County harm track where no CDRH license had ever been issued and the San Diego County harm track where the facility had never obtained any CDPH facility license), or that the CDRH license expired 14 months before the period at issue (the Orange County harm track) — is the primary Welch anchor under Welch v. Metropolitan Life Ins. Co. 480 F.3d 942 (9th Cir. 2007): a timestamped government record generated by the California Department of Public Health entirely outside the attorney's control, confirming whether the respondent held a valid § 1250.3 CDRH license on the dates the medically managed inpatient detoxification services at issue were provided.

The facilities.cdph.ca.gov HFIS verification is supplemented by secondary institutional confirmation from DHCS Substance Use Disorder Compliance Division records, the DEA Certificate of Registration database, and SAMHSA N-SSATS. DHCS SUDCD licensing records confirm whether the facility held a DHCS SUD Residential license under Health & Safety Code § 11834.01 or a DHCS OTP license under Health & Safety Code § 11835 — establishing for the Los Angeles County harm track that the facility held neither a CDPH CDRH license nor any DHCS SUD license and was therefore operating a medically managed detoxification program outside any recognized California licensing framework; and for the San Diego County harm track that the facility held no license of any kind authorizing the provision of substance use disorder treatment to inpatients. The DHCS SUDCD records also confirm that a DHCS residential SUD license does not authorize medically managed detoxification requiring 24-hour physician supervision, benzodiazepine administration, or buprenorphine induction — thereby establishing why the § 1250.3 CDRH license is the correct and required license for the services at issue, rather than the less stringent DHCS residential license. The DEA Certificate of Registration database — maintained by the Drug Enforcement Administration and providing public verification of current DEA registrations for practitioners and facilities — confirms whether the facility and its prescribing physicians held active DEA Schedule III-V registrations authorizing buprenorphine prescribing for opioid use disorder treatment (which requires a specific DEA waiver in addition to the base DEA registration) and whether any Schedule IV registration covered benzodiazepine prescribing for alcohol withdrawal management; for the Orange County harm track, the DEA records confirm that the five undocumented buprenorphine induction events involved a Schedule III controlled substance requiring physician-level DEA registration and documentation, establishing both the controlled-substance nature of the violations and the specific documentation failures at issue. SAMHSA's National Survey of Substance Abuse Treatment Services (N-SSATS) database provides a cross-reference confirming the services the facility reported offering in national data submissions versus the services for which it held valid licensure. Requesting, reviewing, and documenting all secondary institutional records — DHCS SUDCD licensing records, DEA Certificate of Registration database, and SAMHSA N-SSATS records — requires 0.50 hours. Completing the facilities.cdph.ca.gov HFIS verification, reviewing the facility license record including the absence or expiration of the § 1250.3 CDRH license, drafting the CDRH license verification memo documenting the license absence or specific expiration status, and preparing the scope-of-practice analysis distinguishing the CDPH CDRH license from the CDPH GACH license, PHF license, DHCS SUD Residential license, and DHCS OTP license requires 0.75 hours.

After the institutional anchors are established, Billing Gap 1 continues with the ASAM Criteria for Level 4.0 Medically Managed Intensive Inpatient Services advisory — the first of the two private standards in the CDPH CDRH fee petition pattern. The American Society of Addiction Medicine — founded in 1954 and headquartered in Chevy Chase, Maryland — is the national medical specialty society representing physicians who specialize in the prevention, evaluation, diagnosis, and treatment of addiction, with 6,000+ physician members including board-certified addiction medicine specialists, addiction psychiatrists, and other physicians with formal training in addiction medicine. ASAM publishes the ASAM Criteria — the most widely used and clinically validated tool for determining appropriate levels of care for addiction treatment in the United States — which describes five levels of care (0.5 Early Intervention, 1.0 Outpatient Services, 2.0 Intensive Outpatient/Partial Hospitalization, 3.0 Residential/Inpatient Services, and 4.0 Medically Managed Intensive Inpatient Services) based on multidimensional patient assessment. Level 4.0 is the highest level of care and applies to patients whose addiction severity, withdrawal risk, and medical or psychiatric complications require around-the-clock medical management in a licensed inpatient hospital facility. The ASAM Criteria for Level 4.0 is a private clinical standards publication — not a California statutory enactment — and creates no private civil right of action and no mandatory attorney fee-shifting mechanism for patients harmed by unlicensed CDRH operation in California. Three ASAM Level 4.0 criteria are directly applicable to the unlicensed or expired-license CDRH harm pattern. First, ASAM Criterion A — Facility Licensure Prerequisite for Level 4.0 Designation: establishes that a facility claiming to provide ASAM Level 4.0 Medically Managed Intensive Inpatient Services must hold all legally required state facility licenses as a non-negotiable prerequisite for Level 4.0 designation — in California, this means an active CDPH § 1250.3 CDRH license is the required facility-level credential for Level 4.0 status; a facility providing medically managed inpatient detoxification services without a CDPH CDRH license is providing Level 4.0 services outside the licensed hospital setting required by ASAM Criterion A, creating a false representation of ASAM Level 4.0 status regardless of the clinical intensity of services provided; and patient referral sources including hospital discharge planners, insurance case managers, and treating physicians who rely on ASAM Level 4.0 designation in making placement decisions have the right to rely on that designation reflecting a facility that actually holds the required CDPH § 1250.3 CDRH license. Criterion A applies to all three harm tracks: the Los Angeles County facility that had never held a § 1250.3 CDRH license, the Orange County facility whose CDRH license expired 14 months before the investigation period, and the San Diego County facility that had never obtained any CDPH facility license. Second, ASAM Criterion B — Medically Managed Withdrawal Protocols: establishes that Level 4.0 services require the clinical infrastructure to implement evidence-based medically managed withdrawal protocols, including: (a) the CIWA-Ar symptom-triggered benzodiazepine dosing protocol for alcohol withdrawal syndrome — requiring a licensed physician to assess CIWA-Ar scores at defined intervals and order IV lorazepam, oral diazepam, or oral chlordiazepoxide on a symptom-triggered basis calibrated to CIWA-Ar severity, with escalation criteria for CIWA-Ar scores indicating severe withdrawal risk (score ≥15), withdrawal seizure history, prior delirium tremens episodes, or co-occurring medical conditions (hepatic insufficiency, electrolyte abnormalities, cardiac arrhythmias) that increase benzodiazepine metabolism or seizure threshold; (b) COWS-based buprenorphine induction for opioid withdrawal — requiring COWS scoring at the time of induction to confirm sufficient opioid abstinence to prevent precipitated withdrawal, physician-level controlled substance prescribing authority for buprenorphine under DEA Schedule III with X-waiver, and documented COWS monitoring during the induction period for precipitated withdrawal signs; and (c) 24-hour physician monitoring of withdrawal severity including vital sign monitoring at defined intervals for patients with CIWA-Ar scores indicating moderate-to-severe withdrawal risk, ECG monitoring for patients at risk of QT prolongation during methadone or certain benzodiazepine regimens, and immediate physician availability to respond to acute withdrawal complications. Criterion B is directly applicable to the Los Angeles County harm track, where 23 patients received IV benzodiazepines for alcohol withdrawal and supervised opioid tapers in a facility that had never held a CDPH § 1250.3 CDRH license and lacked the physician staffing infrastructure required for ASAM Criterion B CIWA-Ar management, resulting in three acute medical emergencies — an alcohol withdrawal seizure with status epilepticus, a case of severe delirium tremens with hyperthermia and autonomic instability, and an opioid overdose during a supervised taper — all three of which required emergency transfer to a licensed GACH for acute hospital-level care that the unlicensed facility was not equipped to provide. Third, ASAM Criterion F — Placement Criteria and Six-Dimension Assessment: establishes that Level 4.0 placement decisions must be supported by a formal six-dimension ASAM assessment addressing: (1) severity of intoxication or withdrawal potential — confirming that the patient presents with severe withdrawal risk (CIWA-Ar score ≥20 at admission, history of prior withdrawal seizures or delirium tremens, or medically complex withdrawal requiring IV medication) that cannot be safely managed at a lower level of care; (2) biomedical conditions and complications — confirming that the patient's co-occurring medical conditions (hepatic disease, cardiovascular disease, pulmonary disease, severe nutritional deficiency including thiamine depletion risk for Wernicke's encephalopathy) require the medical monitoring and intervention capability of a licensed hospital setting; (3) emotional, behavioral, and cognitive conditions; (4) readiness to change; (5) relapse and continued use potential; and (6) recovery environment. Criterion F is directly applicable to the San Diego County harm track, where 6 patients whose clinical presentations required ASAM Criterion F Level 4.0 placements — in a medically supervised detoxification setting with licensed physician oversight, registered nursing coverage, and controlled substance administration capability — received treatment in a facility operating without any licensed physician and without any registered nurse, meaning no ASAM Criterion F placement assessment was performed and no Level 4.0 withdrawal management plan was implemented, leaving patients in a setting without the clinical infrastructure to recognize or respond to withdrawal complications. ASAM is a private professional organization — the ASAM Criteria create no statutory fee-shifting and no mandatory attorney fee-shifting mechanism. PURE KETCHUM: the attorney fee entitlement flows from CCP § 1021.5. Drafting the ASAM Criteria Level 4.0 advisory memo — including the Criterion A active CDPH § 1250.3 CDRH license prerequisite analysis for all three harm tracks, the Criterion B medically managed withdrawal protocol deviation analysis for the Los Angeles County three-emergency harm track, the Criterion F placement criteria absence analysis for the San Diego County no-physician harm track, the ASAM organizational background and addiction medicine specialty society role, and the PURE KETCHUM fee entitlement framework — requires 1.50 hours.

The ASAM Criteria advisory is immediately followed by the NAATP Standards for Member Programs advisory — the second private standard that makes this CDPH CDRH Billing Gap 1 the only billing gap in the California professional licensing board fee-petition-mechanics series with BOTH an ASAM CRITERIA FOR LEVEL 4.0 MEDICALLY MANAGED INTENSIVE INPATIENT SERVICES (2023 EDITION) ADVISORY AND a NAATP STANDARDS FOR MEMBER PROGRAMS (2023 EDITION) ADVISORY — TWO PRIVATE STANDARDS ON ONE PAGE. The National Association of Addiction Treatment Providers — founded in 1978 and headquartered in Alexandria, Virginia — is the national trade association for addiction treatment programs with 500+ member programs across all levels of care from outpatient to medically managed inpatient; NAATP develops organizational program standards for member programs covering governance, clinical quality, physician oversight, emergency preparedness, and community accountability. The NAATP Standards advisory is a separate billing category from the ASAM Criteria advisory because it originates from a distinct organization — a national trade association that addresses organizational governance and emergency response infrastructure rather than a medical specialty society governing clinical placement and withdrawal management criteria — and addresses physician medical director governance, naloxone emergency response protocols, and GACH transfer agreement requirements (organizational and administrative standards) that the ASAM Criteria, which govern clinical assessment and withdrawal management, do not independently address. Three NAATP Standards are directly applicable to the unlicensed or expired-license CDRH harm pattern. First, NAATP Standard 1 — Program Licensure Prerequisite for NAATP Member Standing: establishes that every NAATP member program must hold all state-required licenses for the services it provides as a non-negotiable condition of NAATP membership — for California CDRHs, an active CDPH § 1250.3 CDRH license is the foundational prerequisite, and a program providing medically managed inpatient detoxification without a valid CDPH CDRH license is ineligible for NAATP membership standing and cannot represent itself as a NAATP member program. Standard 1 applies to all three harm tracks. Second, NAATP Standard 4 — Physician Medical Director Governance and 24-Hour Coverage: requires that NAATP member programs providing medically managed inpatient detoxification services maintain a physician medical director who holds an active, unrestricted California physician and surgeon license, holds board certification or documented specialty training in addiction medicine or a related specialty, provides direct clinical oversight of all withdrawal management protocols and medication regimens, and ensures 24-hour physician coverage during all active treatment hours through on-site physician presence during high-acuity detoxification periods and formal on-call physician availability outside active treatment hours; the medical director must maintain documented oversight of all CIWA-Ar and COWS protocols in use at the facility, approve all clinical standing orders for withdrawal management medications, and review all cases where withdrawal severity escalation criteria were triggered. Standard 4 is directly applicable to the San Diego County harm track, where 6 patients received treatment in a purported CDRH without any licensed physician on staff — no physician medical director had been appointed, no NAATP Standard 4 24-hour physician coverage was in place, and no physician oversight of withdrawal management was available; the unlicensed counselors providing treatment were operating entirely outside the Standard 4 physician governance framework and without the clinical credentials to recognize or respond to acute withdrawal complications that a physician medical director under Standard 4 would have been required to address. Third, NAATP Standard 7 — Naloxone Emergency Response Protocols and GACH Transfer Agreements: requires that all NAATP member CDRHs maintain: (a) on-site naloxone (intramuscular naloxone at minimum, intranasal naloxone for staff-wide availability) with staff trained in opioid reversal administration — naloxone availability is a baseline emergency preparedness requirement for any program providing care to patients with opioid use disorder, where the risk of opioid overdose during detoxification (particularly during supervised taper regimens) is a foreseeable clinical emergency that naloxone is specifically designed to reverse; (b) executed transfer agreements with at least one licensed General Acute Care Hospital confirming the GACH's willingness to accept CDRH patients requiring acute hospital-level care, the agreed-upon transfer protocols, the contact information for the GACH's accepting physician or charge nurse, and the transportation arrangements for non-ambulance transfers; (c) written emergency transfer protocols documenting the specific criteria triggering emergency transfer to a GACH (CIWA-Ar score escalation despite protocol medication, withdrawal seizure onset, delirium tremens with altered sensorium, opioid overdose unresponsive to naloxone, cardiac arrhythmia, or other acute medical emergency), the specific transfer procedure including who contacts the receiving GACH, who accompanies the patient during transfer, and what clinical information is transmitted with the patient; and (d) staff training on naloxone administration and emergency transfer protocol execution at defined intervals. Standard 7 is directly applicable to the Los Angeles County harm track, where 3 patients suffering acute medical emergencies — alcohol withdrawal seizure with status epilepticus, severe delirium tremens, and opioid overdose during supervised taper — required emergency transfer to a licensed GACH, but the unlicensed facility had no executed GACH transfer agreement and no documented naloxone availability, meaning the three emergency transfers were managed without the organizational infrastructure that NAATP Standard 7 requires: no pre-existing GACH transfer agreement to facilitate coordinated receiving, no written transfer protocol to guide staff response, and no documentation confirming naloxone was available and administered for the opioid overdose case. NAATP is a private trade association — the NAATP Standards create no statutory fee-shifting and no mandatory attorney fee-shifting mechanism. PURE KETCHUM: the attorney fee entitlement flows from CCP § 1021.5. Drafting the NAATP Standards advisory memo — including the Standard 1 active CDPH § 1250.3 CDRH license prerequisite analysis for all three harm tracks, the Standard 4 physician medical director 24-hour coverage absence analysis for the San Diego County no-physician track, the Standard 7 naloxone protocol and GACH transfer agreement absence analysis for the Los Angeles County three-emergency track, the NAATP organizational background and addiction treatment trade association role, the PURE KETCHUM distinction from ASAM Criteria, and the non-duplicative billing analysis under Hensley v. Eckerhart — requires 1.00 hour for the NAATP advisory and 1.50 hours for client intake and CCP § 1021.5 pre-suit correspondence, bringing the total Billing Gap 1 time — facilities.cdph.ca.gov HFIS verification (0.75 hrs), DHCS SUDCD, DEA registration, and SAMHSA N-SSATS secondary institutional anchors (0.50 hrs), ASAM Criteria Level 4.0 advisory (1.50 hrs), NAATP Standards advisory (1.00 hr), and client intake and pre-suit (1.50 hrs) — to 5.25 hours, recoverable at $300–$500/hr under the Ketchum lodestar.

Billing gap 2 — Tyler Odyssey complaint filing and three-track harm documentation (4.00 hrs)

Billing Gap 2 begins when the attorney files the civil complaint through Tyler Technologies Odyssey File & Serve — California's electronic court filing platform used by the superior courts in Los Angeles, San Francisco, Alameda, Contra Costa, San Diego, Orange, Riverside, San Bernardino, Sacramento, Santa Clara, Ventura, and the majority of California's 58 counties, covering the geographic markets where § 1250.3 unlicensed CDRH operation most frequently arises because California's combination of high demand for medically supervised detoxification services, complex overlapping regulatory frameworks covering substance use disorder treatment, and large population centers with significant opioid and alcohol use disorder prevalence creates conditions in which unlicensed CDRH operators emerge: residential treatment programs that attempt to expand from DHCS SUD Residential licensure to medically managed detoxification without obtaining the CDPH CDRH license required for hospital-level services; licensed CDRHs whose § 1250.3 licenses lapse during ownership transitions, financial difficulties, or administrative oversights while continuing to admit patients for medically managed detoxification; and operators who market social model or non-medical detoxification programs as "medical detox" without any physician on staff and without any CDPH facility license. The Tyler Odyssey filing timestamp constitutes the primary contemporaneous record under Welch v. Metropolitan Life Ins. Co. 480 F.3d 942 (9th Cir. 2007): it is a government-generated, immutable record establishing the date, case number, parties, and relief sought, created by a system entirely outside the attorney's control at the exact moment of filing. In a California CDRH matter under Health & Safety Code § 1250.3, the complaint alleges violation of § 1250.3 — operating a facility meeting the definition of a Chemical Dependency Recovery Hospital (providing medically managed inpatient detoxification under physician supervision) without an active CDPH CDRH license, a violation not cured by holding a DHCS SUD Residential license (which authorizes residential non-medical treatment, not medically managed detoxification), a DHCS OTP license (which authorizes outpatient opioid maintenance, not inpatient hospital-level detoxification), or any other license that does not authorize medically managed inpatient chemical dependency treatment requiring 24-hour physician supervision and controlled substance administration — violation of CCP § 1021.5 by seeking enforcement of an important right affecting the public interest, specifically the requirement that all California medically managed inpatient detoxification be provided only by CDPH-licensed CDRHs operating under CDPH oversight and ASAM and NAATP standards — and seeks injunctive relief, civil penalties, and mandatory attorney fees under CCP § 1021.5. Drafting, reviewing, and filing the complaint through Tyler Odyssey requires 1.25 hours of Billing Gap 2 time. The three-track harm documentation phase begins with the retention and briefing of qualified expert witnesses under Sargon Enterprises, Inc. v. University of Southern California (2012) 55 Cal.4th 747. In a § 1250.3 CDPH CDRH matter with the three identified harm tracks, the appropriate expert witnesses are: (1) a board-certified addiction medicine physician with ASAM Criteria expertise — to address the Los Angeles County unlicensed CDRH harm track, specifically the ASAM Criterion B medically managed withdrawal protocol deviation analysis for the three acute medical emergencies arising from IV benzodiazepine management and supervised opioid taper without CDPH CDRH licensing and physician oversight infrastructure, the NAATP Standard 7 naloxone and GACH transfer agreement absence analysis, and the ASAM Criterion A Level 4.0 licensing prerequisite; (2) a healthcare regulatory compliance expert specializing in California health facility licensure — to address the Orange County expired-license harm track, specifically the NAATP Standard 1 active CDRH license prerequisite analysis, the ASAM Criterion A Level 4.0 designation prerequisite analysis, and the DEA controlled substance documentation requirements for the five undocumented buprenorphine induction events; and (3) a licensed chemical dependency nursing or CDRH program administration expert — to address the San Diego County no-physician harm track, specifically the NAATP Standard 4 physician medical director 24-hour coverage requirement, the ASAM Criterion F placement criteria six-dimension assessment requirement, and the clinical infrastructure required for registered nursing care of patients in medically managed detoxification. Briefing all three experts requires 1.00 hour of Billing Gap 2 attorney time.

Track 1 harm documentation — LOS ANGELES COUNTY — UNLICENSED CHEMICAL DEPENDENCY RECOVERY HOSPITAL — facilities.cdph.ca.gov HFIS CONFIRMS NO ACTIVE § 1250.3 CDRH LICENSE — 23 PATIENTS — 16-MONTH UNLICENSED PERIOD — IV BENZODIAZEPINES AND OPIOID WITHDRAWAL MANAGEMENT — 3 ACUTE MEDICAL EMERGENCIES REQUIRING GACH TRANSFER — CDPH IMMEDIATE JEOPARDY DETERMINATION — CRIMINAL REFERRAL — $285,000. An unlicensed facility in Los Angeles County operated as an inpatient chemical dependency recovery hospital, providing medically managed detoxification services to patients with alcohol use disorder and opioid use disorder over a 16-month operating period. The facility had never obtained a CDPH § 1250.3 CDRH license — a facilities.cdph.ca.gov HFIS search confirmed no active CDRH license record under the facility name, address, or any associated entity. The facility also held no DHCS SUD Residential license and no DHCS OTP license; it was operating entirely outside any California licensing framework for substance use disorder treatment. During the 16-month operating period, 23 patients were admitted for medically managed detoxification, including patients with severe alcohol use disorder requiring IV benzodiazepine management and patients with opioid use disorder requiring supervised opioid taper regimens. The facility administered IV lorazepam using CIWA-Ar-styled protocols, but without the physician staffing infrastructure required by ASAM Criterion B for CIWA-Ar management — CIWA-Ar assessments were being performed by unlicensed staff who then administered IV medications without real-time physician supervision or documented physician orders covering the symptom-triggered dosing thresholds. Three acute medical emergencies arose from the absence of CDPH CDRH licensing, physician oversight, and NAATP Standard 7 emergency preparedness: (1) a patient with severe alcohol use disorder and undisclosed hepatic insufficiency developed an alcohol withdrawal seizure that progressed to status epilepticus — prolonged seizure activity exceeding five minutes that required IV benzodiazepine rescue dosing and emergency airway management unavailable at the unlicensed facility, necessitating 911 activation and emergency transfer to a licensed GACH where the patient required intubation and ICU-level monitoring; (2) a second patient developed severe delirium tremens with hyperthermia (core temperature 39.8°C), tachycardia (heart rate 138 beats per minute), diaphoresis, and gross tremor — symptoms requiring IV benzodiazepine dose escalation beyond what the facility had ordered, IV fluid replacement, temperature management, and cardiac monitoring, all of which were unavailable at the unlicensed facility; the patient was transferred to a licensed GACH where he required two days of monitored medical management before neurological clearing; and (3) a third patient undergoing a supervised opioid taper for prescription opioid dependence experienced an opioid overdose — respiratory depression with oxygen saturation declining to 87% on room air — that required naloxone administration; the facility had no documented naloxone availability, no NAATP Standard 7 naloxone protocol, and was not equipped to administer naloxone; 911 was activated and the patient was transferred to a licensed GACH emergency department. The facility had no executed GACH transfer agreement and no written emergency transfer protocol — the three emergency transfers were ad hoc responses to life-threatening emergencies in a facility without the organizational infrastructure that NAATP Standard 7 requires. CDPH received a complaint from the family of the status epilepticus patient and conducted an unannounced investigation confirming the unlicensed CDRH operations, the 23 patient admissions, the IV benzodiazepine administration, and the three emergency transfers. CDPH issued an Immediate Jeopardy determination and referred the matter for criminal prosecution. CCP § 1021.5 fee petition: $285,000. Documenting Track 1 requires 0.50 hours of Billing Gap 2 time. Track 2 harm documentation — ORANGE COUNTY — CDPH CDRH LICENSE EXPIRED 14 CONTINUOUS MONTHS — 5 UNDOCUMENTED MAT EVENTS — BUPRENORPHINE INDUCTIONS WITHOUT PHYSICIAN DOCUMENTATION — DCA ADMINISTRATIVE CITATION — $195,000. An Orange County CDRH had held an active CDPH § 1250.3 CDRH license and NAATP membership for several years prior to the period at issue. The CDPH § 1250.3 CDRH license expired 14 months before the DCA investigation when the CDRH failed to submit the annual renewal application and renewal fee. During the 14-month post-expiration period, the CDRH continued admitting patients, including patients with opioid use disorder for whom buprenorphine induction was performed as part of the medically managed detoxification protocol. Five buprenorphine induction events were performed during the unlicensed period without physician documentation — the prescribing physician had not generated COWS assessments, pre-induction pregnancy test documentation, or signed medication orders for any of the five induction events, creating both § 1250.3 CDRH licensing violations and DEA controlled substance documentation failures for Schedule III buprenorphine administration. DCA investigation confirmed the 14-month CDPH § 1250.3 license expiration from the HFIS record, the continued patient admissions, and the five undocumented buprenorphine induction events from facility records and prescribing logs. DCA issued an administrative citation: $195,000. Documenting Track 2 requires 0.75 hours of Billing Gap 2 time. Track 3 harm documentation — SAN DIEGO COUNTY — 6 PATIENTS — NO LICENSED PHYSICIAN — NO REGISTERED NURSE — ONLY UNLICENSED COUNSELORS — DCA ADMINISTRATIVE CITATION — $95,000. A San Diego County operator marketed and operated a "medical detox" program, admitting 6 patients for what was represented as medically supervised detoxification from alcohol and opioids. The facilities.cdph.ca.gov HFIS search confirmed no active § 1250.3 CDRH license, no § 1250.2 PHF license, and no other CDPH facility license. DHCS SUDCD records confirmed no DHCS SUD Residential license and no DHCS OTP license. The facility employed only unlicensed substance use disorder counselors — no licensed physician, no registered nurse, no licensed vocational nurse. The physician whose name appeared on the facility's marketing materials as "Medical Director" had no active California Medical Board license and had never held a formal employment or consulting agreement with the facility. Patients underwent what was described as "medical detox" involving abstinence monitoring, hydration support, over-the-counter comfort medications, and counseling without any controlled substance administration or physician-ordered medical intervention — meaning the services provided were a social model detoxification program being marketed as a CDPH-licensed medical facility. CDPH received a complaint from a patient whose family had paid for "medical detox" and received no medical services, and DCA confirmed the absence of CDPH § 1250.3 CDRH licensing, no licensed physician, and no registered nurse. DCA issued an administrative citation: $95,000. Documenting Track 3 requires 0.50 hours of Billing Gap 2 time. The total Billing Gap 2 time — complaint filing (1.25 hrs), expert retention and briefing (1.00 hr), Track 1 documentation (0.50 hrs), Track 2 documentation (0.75 hrs), and Track 3 documentation (0.50 hrs) — sums to 4.00 hours.

Billing gap 3 — fee petition, lodestar, Ketchum multiplier, and fees-on-fees (4.00 hrs)

Billing Gap 3 in the California CDPH CDRH fee-petition-mechanics pattern is the fee petition itself — the formal court filing presenting the attorney's lodestar calculation, requesting a Ketchum enhancement, and seeking fees-on-fees for the time spent preparing the petition. California's mandatory attorney fee petition practice in professional licensing matters is governed by the lodestar methodology established by the United States Supreme Court in Hensley v. Eckerhart 461 U.S. 424 (1983) and adopted by the California Supreme Court as the standard for calculating reasonable attorney fees under California fee-shifting statutes including CCP § 1021.5. Under the lodestar methodology, the reasonable fee is the product of the reasonable number of hours expended on the litigation multiplied by the reasonable hourly rate — the lodestar figure — which may then be adjusted upward based on the Ketchum v. Moses 24 Cal.4th 1122 (2001) and PLCM Group Inc. v. Drexler 22 Cal.4th 1084 (2000) factors. Drafting the fee petition for a § 1250.3 CDPH CDRH matter requires the attorney to assemble the complete billing record — all ClaimHour-generated contemporaneous time entries for Billing Gaps 1, 2, and 3 — and present them in a format satisfying Welch v. Metropolitan Life Ins. Co. 480 F.3d 942 (9th Cir. 2007): each entry must show the date, timekeeper, hours, and description sufficiently specific to allow evaluation of the reasonableness of the time claimed. In a § 1250.3 CDPH CDRH matter, the fee petition declaration must address the technical content of the ASAM Criteria Level 4.0 advisory and the NAATP Standards advisory — explaining why reviewing ASAM Criterion A active CDRH license prerequisite analysis for all three harm tracks, ASAM Criterion B medically managed withdrawal protocol deviation analysis for the Los Angeles County three-emergency harm track including CIWA-Ar benzodiazepine management deficiencies and status epilepticus causation, ASAM Criterion F placement criteria six-dimension assessment absence analysis for the San Diego County no-physician harm track, NAATP Standard 1 active CDRH license prerequisite for all three harm tracks, NAATP Standard 4 physician medical director 24-hour coverage absence analysis for the San Diego County track, and NAATP Standard 7 naloxone protocol and GACH transfer agreement absence analysis for the Los Angeles County three-emergency track required the specific time claimed — and identifying the board-certified addiction medicine physician expert, the California health facility licensure compliance expert, and the CDRH program administration expert whose involvement the attorney coordinated under Sargon Enterprises v. USC (2012) 55 Cal.4th 747. Drafting the fee petition and supporting declaration requires 1.50 hours of Billing Gap 3 time. The lodestar calculation proceeds from the community standard hourly rate under PLCM Group Inc. v. Drexler 22 Cal.4th 1084 (2000): the prevailing market rate in the relevant community for attorneys of comparable skill, experience, and reputation performing the same type of work. For professional licensing fee petition work involving unlicensed chemical dependency recovery hospital claims in Los Angeles County, Orange County, and San Diego County — three of California's highest-volume counties for substance use disorder treatment, where unlicensed CDRH operator enforcement is an active area of CDPH healthcare enforcement because of the combination of high demand for medically managed detoxification services, the complex overlapping regulatory framework governing substance use disorder treatment, and the severe patient safety consequences of detoxification in an unlicensed facility without adequate medical oversight — the prevailing market rate for experienced healthcare regulatory and professional licensing enforcement attorneys ranges from $300 per hour at the lower end to $500 per hour at the higher end. At $300/hr, the 13.25 annual hours across the three billing gaps produce a lodestar of $3,975. At $500/hr, the same hours produce a lodestar of $6,625. Calculating the lodestar and preparing the rate declaration requires 0.75 hours of Billing Gap 3 time.

The Ketchum multiplier analysis distinguishes California professional licensing fee petition practice from federal fee-shifting practice. In Ketchum v. Moses 24 Cal.4th 1122 (2001), the California Supreme Court held that the lodestar may be adjusted for contingent risk, novelty and complexity, skill, results achieved, and preclusion of other employment. In a § 1250.3 California CDPH CDRH matter, the Ketchum multiplier analysis focuses on three enhancement arguments: (1) the contingent risk — unlicensed CDRH operation typically presents significant collection uncertainty and enforcement complexity because unlicensed operators have not invested in the clinical infrastructure, physician staffing, and compliance systems that licensed CDRHs maintain; the Los Angeles County unlicensed CDRH that administered IV benzodiazepines and supervised opioid tapers to 23 patients without CDPH § 1250.3 licensing, without ASAM Criterion B withdrawal management infrastructure, and without NAATP Standard 7 naloxone and GACH transfer agreements faces simultaneous CDPH Immediate Jeopardy enforcement, criminal prosecution, DCA administrative proceedings, and individual patient liability for the three acute medical emergencies and resulting GACH transfers; the Orange County expired-license CDRH that performed five buprenorphine inductions without physician documentation during a 14-month unlicensed period faces DEA controlled substance audit exposure in addition to CDPH licensing violations, creating a complex multi-agency enforcement environment with uncertain collection; and the San Diego County operator marketing a social model program as "medical detox" without any physician or registered nurse faces consumer protection liability in addition to § 1250.3 CDRH licensing violations, creating exposure for both administrative penalties and private civil claims from the 6 patients who paid for medical services and received non-medical care; (2) the technical complexity — establishing the causal chain between the Los Angeles County unlicensed CDRH's absence of CDPH § 1250.3 licensing, ASAM Criterion B withdrawal management infrastructure, and NAATP Standard 7 emergency preparedness and the three acute medical emergencies requiring GACH transfer requires the attorney to engage a board-certified addiction medicine expert who can explain to a lay trier of fact: why ASAM Level 4.0 licensing is specifically required for patients with severe alcohol use disorder, hepatic insufficiency, and withdrawal seizure history — that these patients require the CIWA-Ar protocol infrastructure, IV medication capability, and 24-hour physician monitoring that only a CDPH § 1250.3-licensed CDRH can lawfully provide; why the absence of an executed NAATP Standard 7 GACH transfer agreement created the specific risk that materialized in the three emergency transfers — that an executed transfer agreement would have pre-designated the receiving GACH, confirmed the transportation protocol, and ensured that the receiving physician had advance notice of the patient's clinical presentation, all of which were absent from the three ad hoc transfers; and why the lack of documented naloxone availability violated NAATP Standard 7 for the opioid overdose emergency — that a NAATP Standard 7-compliant facility would have had intranasal or IM naloxone immediately available and staff trained to administer it, potentially reversing the opioid overdose before it required 911 activation; and establishing the Orange County harm requires a healthcare regulatory compliance expert who can explain why DEA Schedule III controlled substance administration requires both CDPH CDRH licensing and physician-level documentation — that each buprenorphine induction requires a COWS assessment, a documented pregnancy test for female patients, a signed physician medication order specifying the induction dose, and ongoing monitoring notes, and that the five undocumented induction events represent both CDPH § 1250.3 licensing violations and independent DEA Controlled Substances Act documentation failures; (3) the public benefit — Health & Safety Code § 1250.3 and the CDPH CDRH licensing requirement protect California patients undergoing medically managed inpatient detoxification, who are among the most medically vulnerable healthcare consumers — patients in active alcohol or opioid withdrawal face life-threatening medical complications (alcohol withdrawal seizures, delirium tremens, Wernicke's encephalopathy, opioid-induced respiratory depression) that require immediate physician intervention in a licensed facility equipped with IV medication capability, emergency resuscitation equipment, and GACH transfer protocols; the 23-patient unlicensed operation in Los Angeles County, the 14-month continued operation in Orange County, and the 6-patient misrepresented program in San Diego County represent the predictable patient harm that the CDRH licensing requirement exists to prevent; and the three GACH transfers and three acute emergencies in the Los Angeles County track — and particularly the status epilepticus case requiring intubation — represent the most direct expression of the life-threatening risk that CDPH CDRH licensure, ASAM Criterion B withdrawal management protocols, and NAATP Standard 7 emergency preparedness exist to prevent. A Ketchum multiplier of 1.5 applied to the $6,625 lodestar maximum produces an enhanced fee of $9,937. PURE KETCHUM: because there is no concurrent federal claim — Health & Safety Code § 1250.3 and CCP § 1021.5 are California statutes governed by California fee-shifting law — this enhancement faces no Burlington Northern Railroad Co. v. Dague 505 U.S. 557 (1992) constraint. Drafting the Ketchum multiplier section requires 1.00 hour of Billing Gap 3 time. The final component of Billing Gap 3 is the fees-on-fees calculation under Missouri v. Jenkins 491 U.S. 274 (1989): California courts apply the same rule to CCP § 1021.5, making all 4.00 hours of Billing Gap 3 work fully recoverable. Fees-on-fees in a § 1250.3 CDPH CDRH matter ensure that the fully recovered annual fee reaches $3,975–$6,625 across all 13.25 hours — the fee petition drafting (1.50 hrs), the lodestar calculation (0.75 hrs), the Ketchum multiplier analysis (1.00 hr), and the fees-on-fees calculation itself (0.75 hrs) — without the attorney absorbing any petition preparation time as non-recoverable overhead. At $300/hr, 4.00 hours add $1,200 in fees-on-fees; at $500/hr, the same hours add $2,000. Drafting the fees-on-fees calculation and Missouri v. Jenkins citation block requires 0.75 hours of Billing Gap 3 time. The total Billing Gap 3 time — fee petition drafting (1.50 hrs), lodestar calculation (0.75 hrs), Ketchum multiplier analysis (1.00 hr), and fees-on-fees calculation (0.75 hrs) — sums to 4.00 hours, bringing the complete three-billing-gap total to 13.25 hours and the annual recoverable fee range to $3,975–$6,625 per year at $300–$500 per hour, subject to Ketchum enhancement at the court's discretion.